Multiple sclerosis produces significant changes in urinary bladder innervation which are partially reflected in the lower urinary tract functional status-sensory nerve fibers role in detrusor overactivity

Multiple Sclerosis

Volumn 15, Issue 7, 2009, Pages 860-868

  Radziszewski, Piotr ^a   Crayton, R ^a   Zaborski, J ^b   Czlonkowska A ^a   Borkowski, A ^a   Bossowska, A ^c   Majewski, M ^c  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Laboratory of Nuclear Medicine   (Poland)

^c UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

Author keywords

Capsaicin; Detrusor overactivity; Multiple sclerosis; Vanilloid

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; GALANIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ARTICLE; BLADDER BIOPSY; BLADDER CAPACITY; BLADDER CONTRACTION; BLADDER FILLING; BLADDER INNERVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DETRUSOR MUSCLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOWER URINARY TRACT SYMPTOM; MALE; MICTURITION; MULTIPLE SCLEROSIS; NERVE FIBER; OVERACTIVE BLADDER; SENSORY NERVE; URINARY TRACT FUNCTION; URINE FLOW RATE; UROTHELIUM;

ADULT; BIOPSY; CALCITONIN GENE-RELATED PEPTIDE; CASE-CONTROL STUDIES; CYSTOSCOPY; FEMALE; HEMATURIA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE SCLEROSIS; NEURAL PATHWAYS; SENSORY RECEPTOR CELLS; SUBSTANCE P; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; URODYNAMICS; UROTHELIUM;

EID: 67649306712     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509106210     Document Type: Article

References (60)

1. Altmann, D. Evaluating the evidence for multiple sclerosis as an autoimmune disease. Arch Neurol 2005; 62: 688.
2. Bansil, S, Cook, SD, Rohowsky-Kochan, C. Multiple sclerosis: Immune mechanism and update on current therapies. Ann Neurol 1995; 37(Suppl. 1): S87-S101.
3. Bansil, S, Troiano, R, Rohowsky-Kochan, C, Jotkowitz, A, Dowling, PC, Cook, SD. Multiple sclerosis: Pathogenesis and treatment. Semin Neurol 1994; 14: 146-153.
4. Lassmann, H. Experimental models of multiple sclerosis. Rev Neurol (Paris) 2007; 163: 651-655.
5. DasGupta, R, Fowler, CJ. Sexual and urological dysfunction in multiple sclerosis: Better understanding and improved therapies. Curr Opin Neurol 2002; 15: 271-278.
6. Hinson, JL, Boone, TB. Urodynamics and multiple sclerosis. Urol Clin North Am 1996; 23: 475-481.
7. Janig, W, Morrison, JF. Functional properties of spinal visceral afferents supplying abdominal and pelvic organs, with special emphasis on visceral nociception. Prog Brain Res 1986; 67: 87-114.
8. Miller, H, Simpson, CA, Yeates, WK. Bladder dysfunction in multiple sclerosis. Br Med J 1965; 1: 1265-1269
9. De Groat, WC. Integrative control of the lower urinary tract: preclinical perspective. Br J Pharmacol 2006; 147 (Suppl. 2): S25-S40.
10. Fowler, CJ, Beck, RO, Gerrard, S, Betts, CD, Fowler, CG. Intravesical capsaicin for treatment of detrusor hyperreflexia. J Neurol Neurosurg Psychiatry 1994; 57: 169-173.
11. Kruse, MN, Mallory, BS, Noto, H, Roppolo, JR, de Groat, WC. Modulation of the spinobulbospinal micturition reflex pathway in cats. Am J Physiol Regul Integr Comp Physiol 1992; 262: R478-R484.
12. Zinck, ND, Downie, JW. Plasticity in the injured spinal cord: Can we use it to advantage to reestablish effective bladder voiding and continence. Prog Brain Res 2006; 152: 147-162.
13. Avelino, A, Cruz, C, Nagy, I, Cruz, F. Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience 2002; 109: 787-798.
14. Habler, HJ, Janig, W, Koltzenburg, M. Activation of unmyelinated afferent fibres by mechanical stimuli and inflammation of the urinary bladder in the cat. J Physiol 1990; 425: 545-562.
15. Davis, KD, Meyer, RA, Campbell, JN. Chemosensitivity and sensitization of nociceptive afferents that innervate the hairy skin of monkey. J Neurophysiol 1993; 69: 1071-1081.
16. Handwerker, HO, Kilo, S, Reeh, PW. Unresponsive afferent nerve fibres in the sural nerve of the rat. J Physiol 1991; 435: 229-242.
17. Kress, M, Koltzenburg, M, Reeh, PW, Handwerker, HO. Responsiveness and functional attributes of electrically localized terminals of cutaneous C-fibers in vivo and in vitro. J Neurophysiol 1992; 68: 581-595.
18. Neugebauer, V, Schaible, HG, Schmidt, RF. Sensitization of articular afferents to mechanical stimuli by bradykinin. Pflugers Arch 1989; 415: 330-335.
19. Schmidt, RF. Novel classes of responsive and unresponsive C nociceptors in human skin. J Neurosci 1995; 15: 333-341.
20. Tuttle, JB, Steers, WD, Albo, M, Nataluk, E. Neural input regulates tissue NGF and growth of the adult rat urinary bladder. J Auton Nerv Syst 1994; 49: 147-158.
21. De Groat, WC, Kawatani, M, Hisamitsu, T, et al. Mechanisms underlying the recovery of urinary bladder function following spinal cord injury. J Auton Nerv Syst 1990; 30 (Suppl. 7): S71-S77.
22. De Groat, WC, Yoshimura, N. Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury. Prog Brain Res 2006; 152: 59-84.
23. Kim, JC, Kim, DB, Seo II, S, Park, YH, Hwang, T-K. Nerve growth factor and vanilloid receptor expression, and detrusor instability, after relieving bladder outlet obstruction in rats. BJU Int 2004; 94: 915-918.
24. Liu, HT, Chancellor, MB, Kuo, HC. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-a injection. Eur Urol 2008; 30: 30.
25. Lowe, EM, Anand, P, Terenghi, G, Williams-Chestnut, RE, Sinicropi, DV, Osborne, JL. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 1997; 79: 572-577.
26. McMahon, SB, Koltzenburg, M. Novel classes of nociceptors: Beyond Sherrington. Trends Neurosci 1990; 13: 199-201.
27. Micera, A, Lambiase, A, Stampachiacchiere, B, Bonini, S, Bonini, S, Levi-Schaffer, F. Nerve growth factor and tissue repair remodeling: trkA(NGFR) and p75(NTR), two receptors one fate. Cytokine Growth Factor Rev 2007; 18: 245-256.
28. Steers, WD, Kolbeck, S, Creedon, D, Tuttle, JB. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J Clin Invest 1991; 88: 1709-1715.
29. Sundin, T, Dahlstrom, A, Norlen, L, Svedmyr, N. The sympathetic innervation and adrenoreceptor function of the human lower urinary tract in the normal state and after parasympathetic denervation. Invest Urol 1977; 14: 322-328.
30. Bjorling, DE, Beckman, M, Saban, R. Neurogenic inflammation of the bladder. Adv Exp Med Biol 2003; 539: 551-583.
31. Lecci, A, Maggi, CA. Tachykinins as modulators of the micturition reflex in the central and peripheral nervous system. Regul Pept 2001; 101: 1-18.
32. Pennefather, JN, Lecci, A, Candenas, ML, Patak, E, Pinto, FM, Maggi, CA. Tachykinins and tachykinin receptors: A growing family. Life Sci 2004; 74: 1445-1463.
33. Saban, MR, Saban, R, Bjorling, DE. Kinetics of peptideinduced release of inflammatory mediators by the urinary bladder. Br J Urol 1997; 80: 742-747.
34. Szallasi, A. The vanilloid (capsaicin) receptor: Receptor types and species differences. Gen Pharmacol 1994; 25: 223-243.
35. Brady, CM, Apostolidis, A, Harper, M, et al. Parallel changes in bladder suburothelial vanilloid receptor TRPV1 (VR1) and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity (NDO) following intravesical resiniferatoxin treatment. BJU Int 2004; 93: 770-776.
36. Fowler, CJ, Harper, M, Fry, CH. Voiding and the sacral reflex arc: lessons from capsaicin instillation. Scand J Urol Nephrol 2002; 210: 46-50.
37. De Groat, WC, Nadelhaft, I, Milne, RJ, Booth, AM, Morgan, C, Thor, K. Organization of the sacral parasympathetic reflex pathways to the urinary bladder and large intestine. J Auton Nerv Syst 1981; 3: 135-160.
38. Wyndaele, J,Kovindha,A,Madersbacher,H, Radziszewski,P, Ruffion, A, Schurch, B. Neurologic urinary and faecal incontinence. In: Incontinence, Paris: France, Health Publication Ltd; 2009. p. 793.
39. Fowler, CJ, Jewkes, D, McDonald, WI, Lynn, B, Degroat, WC. (letter) Intravesical capsaicin for neurogenic bladder dysfunction. Lancet 1992; 339: 1239.
40. Dasgupta, P, Fowler, CJ. Chillies: From antiquity to urology. Br J Urol 1997; 80: 845-852.
41. Francisco, C, Miguel, G, Carlos, S, Maria Edite, R, Antonio, C, Mario, R. Desensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction. J Urol 1997; 157: 585-589.
42. De Ridder, D, Chandiramani, V, Dasgupta, P, Van Poppel, H, Baert, L, Fowler, CJ. Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: A dual center study with long-term followup. J Urol 1997; 158: 2087-2092.
43. De Seze, M, Wiart, L, De Seze, MP, et al. Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: A doubleblind, randomized, controlled study. J Urol 2004; 171: 251-255.
44. Apostolidis, A, Popat, R, Yiangou, Y, et al. Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 2005; 174: 977-982.
45. Giannantoni, A, Mearini, E, Del Zingaro, M, Santaniello, F, Porena, M. Botulinum a toxin in the treatment of neurogenic detrusor overactivity: a consolidated field of application. BJU Int 2008; 102(Suppl. 1): 2-6.
46. MacDonald, R, Monga, M, Fink, HA, Wilt, TJ. Neurotoxin treatments for urinary incontinence in subjects with spinal cord injury or multiple sclerosis: A systematic review of effectiveness and adverse effects. J Spinal Cord Med 2008; 31: 157-165.
47. Van Poppel, H, Stessens, R, Baert, L, Van Damme, B, Carton, H. Vasoactive intestinal polypeptidergic innervation of human urinary bladder in normal and pathological conditions. Urol Int 1988; 43: 205-210.
48. Moss, H, Tansey, E, Milner, P, Lincoln, J, Burnstock, G. Neuropeptide immunoreactivity and choline acetyltransferase activity in the mouse urinary bladder following inoculation with Semliki Forest Virus. J Auton Nerv Syst 1990; 31: 47-56.
49. Pascual, AM, Martinez-Bisbal, MC, Bosca, I, et al. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis. Neurology 2007; 69: 63-67.
50. De Sèze, M, Wiart, L, Joseph, PA, Dosque, JP, Mazaux, JM, Barat, M. Capsaicin and neurogenic detrusor hyperreflexia: A double-blind placebo-controlled study in 20 patients with spinal cord lesions. Neurourol Urodyn 1998; 17: 513-523.
51. Silva, C, Rio, ME, Cruz, F. Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: Long-term results for the treatment of detrusor hyperreflexia. Eur Urol 2000; 38: 444-452.
52. Dasgupta, P, Chandiramani, VA, Beckett, A, Scaravilli, F, Fowler, CJ. The effect of intravesical capsaicin on the suburothelial innervation in patients with detrusor hyperreflexia. BJU Int 2000; 85: 238-245.
53. Yoshimura, N, De Groat, WC. Plasticity of Na+ channels in afferent neurones innervating rat urinary bladder following spinal cord injury. J Physiol 1997; 503: 269-276.
54. Szallasi, A. Autoradiographic visualization and pharmacological characterization of vanilloid (capsaicin) receptors in several species, including man. Acta Physiol Scand Suppl 1995; 629: 1-68.
55. Szallasi, A, Blumberg, PM. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 1999; 51: 159-212.
56. Kobayashi, K, Fukuoka, T, Obata, K, et al. Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with adelta/ c-fibers and colocalization with trk receptors. J Comp Neurol 2005; 493: 596-606.
57. Kurtzke, JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
58. Lublin, FD, Reingold, SC. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of new agents in multiple sclerosis. Neurology 1996; 46: 907-911.
59. Stohrer, M, Castro-Diaz, D, Chartier-Kastler, E, et al. Guidelines on neurogenic lower urinary tract dysfunction, In: European Association of Urology Guidelines. Arnhem, The Netherlands: European Association of Urology; 2009.
60. Liu, HT, Kuo, HC. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention. Neurourol Urodyn 2009; 28: 78-81.